Search Results

Strategic deactivation of mRNA COVID-19 vaccines: New applications for siRNA therapy and RIBOTACs.

• Authors : Hulscher N; McCullough Foundation, Dallas, Texas, USA.; McCullough PA

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology

• Source: The journal of gene medicine [J Gene Med] 2024 Sep; Vol. 26 (9), pp. e3733.Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9815764 Publication Model: Print Cited Medium: Internet ISSN: 1521-2254

Record details

Authors' Response: Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Controlled and Randomized Clinical Trials.

• Authors : Beladiya J; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, India.; Kumar A

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

• Source: Reviews in medical virology [Rev Med Virol] 2024 Sep; Vol. 34 (5), pp. e2573.Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print Cited Medium: Internet ISSN: 1099-1654 (Electronic)

Record details

COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.

• Authors : Sainz de la Maza S; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Red de Enfermedades Inflamatorias (REI), Madrid, Spain.; Rodero-Romero A

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/immunology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/blood ; COVID-19*/COVID-19*/COVID-19*/immunology

• Source: Frontiers in immunology [Front Immunol] 2024 Aug 22; Vol. 15, pp. 1439393. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink.

• Authors : Boyce TG; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.; McClure DL

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

• Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5863.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Hesitant or Confident: A Qualitative Study Examining Latinos' Perceptions of COVID-19 Vaccines in Arizona

• Authors : Micaela Mercado (ORCID 0000-0002-7750-6048); Gilberto Lopez; Matt Ignacio

Subjects: COVID-19; Latin Americans; Immunization ProgramsArizona

• Source: Health Education & Behavior. 2024 51(4):512-520.9

Record details

Addendum: Effectiveness of mRNA COVID-19 vaccines.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 Oct 14; Vol. 66 (1713), pp. e168. Date of Electronic Publication: 2024 Oct 14.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.

• Authors : Fryer HA; Dept. Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Geers D

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

• Source: The Journal of infection [J Infect] 2024 Oct; Vol. 89 (4), pp. 106246. Date of Electronic Publication: 2024 Aug 08.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Qualitative study on information, trust in and access to COVID-19 vaccines among adolescents at a healthcare center in Buenos Aires.

• Authors : Santomaso CA; Center for Health and Community Action no. 28, City of Buenos Aires, Argentina.; Pavez Rakela P

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; Trust* ; Qualitative Research*

• Source: Archivos argentinos de pediatria [Arch Argent Pediatr] 2024 Oct 01; Vol. 122 (5), pp. e202310281. Date of Electronic Publication: 2024 May 30.Publisher: Sociedad Argentina de Pediatría Country of Publication: Argentina NLM ID: 0372460 Publication Model: Print-Electronic Cited Medium:

Record details

Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis.

• Authors : Ciapponi A; Argentine Cochrane Center, Institute for Clinical Effectiveness and Health Policy (IECS), Ravignani 2024, C1414CPV, Buenos Aires, Argentina. .; Centro de Investigaciones Epidemiológicas y Salud Pública (CIESP-IECS), CONICET, Buenos Aires, Argentina. .

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Drug safety [Drug Saf] 2024 Oct; Vol. 47 (10), pp. 991-1010. Date of Electronic Publication: 2024 Jul 15.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study.

• Authors : Bellitto C; Department of Diagnostics and Public Health, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy.; Luxi N

Subjects: Immunocompromised Host*/Immunocompromised Host*/Immunocompromised Host*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

• Source: Drug safety [Drug Saf] 2024 Oct; Vol. 47 (10), pp. 1011-1023. Date of Electronic Publication: 2024 Jun 22.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details